Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SemeCell Technology is a biotechnology company headquartered in Shenzhen, China, specializing in single-cell sequencing and spatial transcriptomics services. The company provides high-resolution genomic solutions, including single-cell RNA-seq, ATAC-seq, and spatial multi-omics analysis, to academic researchers and pharmaceutical companies. SemeCell's platform integrates advanced laboratory techniques with robust bioinformatics pipelines to help clients explore cellular diversity and tissue architecture. Their services are widely applied in fields such as oncology, immunology, and regenerative medicine to accelerate drug discovery and biomarker identification. By utilizing cutting-edge technologies like 10x Genomics and Stereo-seq, the company offers comprehensive support from sample preparation to deep data mining.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SEME Cell Technology.